Abiopharma

🔍 Bragdon Peter J (Executive)

Company: COLUMBIA SPORTSWEAR CO (COLM)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 157 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 28,074.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 53 shares of Common Stock at $54.59 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 28,021.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: By children | shares_owned_after: 2,250.00 | Footnotes: F3
• Sold 157 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 942.00 | transaction_form_type: 4 | Footnotes: F1, F4, F4

Footnotes:

• F1: Restricted stock units convert to common stock on a one-for-one basis.
• F2: Shares were withheld by the issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units.
• F3: Shares are held by the reporting person's children sharing the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose.
• F4: The grant of 1,256 restricted stock units vests at 12.5% every six months beginning on October 1, 2025. If a vesting date falls on a day on which the securities exchange is closed, affected RSUs shall vest on the next securities exchange business day.